RVMD
As of 2026-11-06, Revolution Medicines, Inc. (RVMD) has a market capitalization of $40.68 B, making it the #374 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $40.68 B |
| 2026-11-05 | $37.77 B |
| 2026-11-04 | $42.51 B |
| 2026-11-03 | $41.29 B |
| 2026-11-02 | $40.00 B |
| 2026-11-01 | $40.67 B |
| 2026-10-31 | $40.67 B |
| 2026-10-30 | $40.15 B |
| 2026-10-29 | $39.88 B |
| 2026-10-28 | $39.95 B |
| 2026-10-27 | $39.59 B |
| 2026-10-26 | $39.10 B |
As of 2026-11-06, Revolution Medicines, Inc. (RVMD) has a market capitalization of $40.68 B, making it the #374 most valuable US-listed company.
Revolution Medicines, Inc. is the #374 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $39.75 B |
| 2026-10-24 | $39.75 B |
| 2026-10-23 | $39.75 B |
| 2026-10-22 | $39.90 B |
| 2026-10-21 | $41.30 B |
| 2026-10-20 | $41.79 B |
| 2026-10-19 | $38.79 B |
| 2026-10-18 | $37.83 B |
| 2026-10-17 | $37.83 B |
| 2026-10-16 | $37.51 B |
| 2026-10-15 | $40.24 B |
| 2026-10-14 | $41.14 B |
| 2026-10-13 | $40.06 B |
| 2026-10-12 | $41.06 B |
| 2026-10-11 | $40.34 B |
| 2026-10-10 | $40.34 B |
| 2026-10-09 | $40.34 B |
| 2026-10-08 | $42.70 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.